Author

Y. C. Chang

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

C.-N. Shen· 1 shared J. C. Hsu· 1 shared J.-C. Tsai· 1 shared J.-S. Lai· 1 shared K.-L. K. Wen· 1 shared M. C. Chang· 1 shared M.-T. Lai· 1 shared P. S. Chang· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

C.-N. Shen

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Manufacturing CD20/CD19-targeted iCasp9 regulatable CAR-TSCM cells using qCART, the Quantum pBac-based CAR-T system

P. S. Chang, Y.-C. Chen, W.-K. Hua, J. C. Hsu, J.-C. Tsai, Y.-W. Huang, Y.-H. Kao, P.-H. Wu, Y.-F. Chang, M. C. Chang, Y. C. Chang, S.-L. Jian, J.-S. Lai, M.-T. Lai, W.-C. Yang, , S. C.-Y. Wu

This paper demonstrates the efficient manufacturing of CD20/CD19 dual-targeted, iCasp9-regulatable CAR-TSCM cells using the virus-free qCART system, showing robust tumor eradication and safety.

bioRxiv · May 3, 2022 · PreprintCancer Biology